-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of petition.
SUMMARY:
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by McCormick & Company, Inc., proposing that the color additive regulations be amended to provide for the safe use of spirulina extract to color shell eggs at levels consistent with good manufacturing practice.
DATES:
The color additive petition was filed on August 24, 2016.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Celeste Johnston, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740-3835, 240-402-1282.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Under section 721(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379e(d)(1)), we are giving notice that we have filed a color additive petition (CAP 6C0306), submitted by McCormick & Company, Inc., c/o Exponent, 1150 Connecticut Ave. NW., Suite 1100, Washington, DC 20036. The petition proposes to amend the color additive regulations in § 73.530 (21 CFR 73.530) Spirulina extract to provide for the safe use of spirulina extract prepared by a water extraction and filtration of the dried biomass of Arthrospira platensis to color shell eggs.
We have determined under 21 CFR 25.32(r) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
Start SignatureDated: September 13, 2016.
Dennis M. Keefe,
Director, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition.
[FR Doc. 2016-22289 Filed 9-15-16; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 09/16/2016
- Department:
- Food and Drug Administration
- Entry Type:
- Proposed Rule
- Action:
- Notice of petition.
- Document Number:
- 2016-22289
- Dates:
- The color additive petition was filed on August 24, 2016.
- Pages:
- 63728-63728 (1 pages)
- Docket Numbers:
- Docket No. FDA-2016-C-2570
- PDF File:
- 2016-22289.pdf
- Supporting Documents:
- » Reference 7 - Memorandum from JPark to MHarry _04252017_Redacted
- » Reference 6 - Memorandum from JPark to MHarry_ 04132017_Redacted
- » Reference 5 - Memorandum from JPark to MHarry_ 02022017__Redacted
- » Reference 4 - Memorandum from LRosenfeld to JPark_01122017_Redacted
- » Reference 2 - Memorandum from HLee to MHarry_02012017_Redacted
- » Reference 1 - Memorandum from NBelai to MHarry_02012017_Redacted
- CFR: (1)
- 21 CFR 73